In response to an increase of Human Metapneumovirus (HMPV) cases in China, the state health department has issued a ...
Two children died of influenza in the Portland area in December, the first such deaths in Oregon this winter, state data show ...
Munson Medical Center has seen an uptick in severe influenza cases.Over the past week, the hospital has seen more ...
The respiratory syncytial virus (RSV) vaccine may not protect older adults who are immunocompromised as much as their healthier peers, according to new research.
A Massachusetts mother is warning other parents about the respiratory risks this season as her young has been hospitalized ...
Cheyenne, Wyo. - According to the U.S. Food and Drug Administration, Braga Fresh is issuing a precautionary advisory of ...
Looking to improve your health in 2025 and beyond? Check out these recommendations from the American Medical Association: ...
The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...
Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity -; primarily organ transplant recipients who take immunosuppressive medications to reduce the risk of ...
The study followed 38 immunocompromised adults, aged 64 to 72, who received either the Arexvy or Abrysvo RSV vaccine. Researchers found that people aged 60 and older who are immunocompromised ...
Researchers have shown that people 60 years or older with weakened immunity do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback